J. Liu

A First‐in‐Patient, Multicenter, Double‐Blind, 2‐Arm, Placebo‐Controlled, Randomized Safety and Tolerability Study of a Novel Oral Drug Candidate, CTP‐499, in Chronic Kidney Disease

J. Neutel, Lijun Wu, L. Sabounjian, 2016, Clinical pharmacology in drug development.

Altering Metabolic Profiles of Drugs by Precision Deuteration: Reducing Mechanism-Based Inhibition of CYP2D6 by Paroxetine

Philip B. Graham, V. Uttamsingh, S. Harbeson, 2015, The Journal of Pharmacology and Experimental Therapeutics.

Determination of capsaicin and dihydrocapsaicin in Capsicum anuum and related products by capillary electrophoresis with a mixed surfactant system

Xingguo Chen, Suiyi Tan, Lihong Liu, 2010 .

Quantitative analyses of CTP-499 and five major metabolites by core-structure analysis.

H. Erol, Lijun Wu, Z. Lin, 2014, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Altering Metabolic Profiles of Drugs by Precision Deuteration 2: Discovery of a Deuterated Analog of Ivacaftor with Differentiated Pharmacokinetics for Clinical Development

V. Uttamsingh, S. Harbeson, R. Tung, 2017, The Journal of Pharmacology and Experimental Therapeutics.

ALTERING METABOLIC PROFILES OF DRUGS BY PRECISION DEUTERATION: REDUCING MECHANISM-BASED INHIBITION OF CYP2D6 BY PAROXETINE

Philip B. Graham, V. Uttamsingh, S. Harbeson, 2015 .

Total Synthesis of (+/-)-Cylindricines A and B.

C. Heathcock, J. Liu, 1999, The Journal of organic chemistry.

A Decade of Deuteration in Medicinal Chemistry

R. Silverman, D. Doller, S. Harbeson, 2017 .

The influence of aggregate microenvironment on the dissolution of oxazepam in ternary surfactant interactive mixtures

P. Stewart, J. Liu, 2002, The Journal of pharmacy and pharmacology.

Altering Metabolic Profiles of Drugs by Precision Deuteration: Reducing Mechanism-Based Inhibition of CYP2D6 by Paroxetine

Philip B. Graham, V. Uttamsingh, S. Harbeson, 2015, Journal of Pharmacology and Experimental Therapeutics.